Middle East & Africa 3d Printed Drugs Market Size & Outlook
Middle East & Africa 3d printed drugs market, 2018-2030 (US$M)
Related Markets
MEA 3d printed drugs market highlights
- The MEA 3d printed drugs market generated a revenue of USD 3.2 million in 2023.
- The market is expected to grow at a CAGR of 11.2% from 2024 to 2030.
- In terms of segment, neurology was the largest revenue generating application in 2023.
- Orthopedic is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 3.2 million |
| Market revenue in 2030 | USD 6.7 million |
| Growth rate | 11.2% (CAGR from 2023 to 2030) |
| Largest segment | Neurology |
| Fastest growing segment | Orthopedic |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Dental, Orthopedic, Neurology |
| Key market players worldwide | GlaxoSmithKline, Hewlett Packard Enterprise Co, Merck KGaA, AstraZeneca PLC, Aprecia Pharmaceuticals, Extend Biosciences, BioDuro, Affini-T Therapeutics, Osmotica Pharmaceutical, FabRx, Cycle Pharmaceuticals |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.1% of the global 3d printed drugs market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 60.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
3D Printed Drugs Market Scope
3D Printed Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa 3d printed drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d printed drugs market will help companies and investors design strategic landscapes.
Neurology was the largest segment with a revenue share of 50% in 2023. Horizon Databook has segmented the Middle East & Africa 3d printed drugs market based on dental, orthopedic, neurology covering the revenue growth of each sub-segment from 2018 to 2030.
Middle Eastern countries such as Saudi Arabia, Qatar, UAE, Kuwait, and Oman are prospering economies. Advancements in the healthcare system are expected to increase the demand for 3D printed drugs in MEA. Furthermore, various initiatives, such as the National Transformation Program of Dubai, which is aimed at fully privatizing healthcare facilities to improve healthcare quality, are expected to drive market growth.
The increase in research activities related to using 3D printing technologies in healthcare is another factor expected to boost market growth. Governments and private entities in the region increasingly recognize the potential of 3D printing in drug manufacturing, boosting investments and encouraging innovation. Furthermore, the rising prevalence of chronic diseases and a growing geriatric population are driving the need for personalized medicine & tailored drug formulations, propelling the demand for 3D printed drugs.
Reasons to subscribe to Middle East & Africa 3d printed drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa 3d printed drugs market databook
-
Our clientele includes a mix of 3d printed drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa 3d printed drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa 3d printed drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA 3d printed drugs market size, by country, 2018-2030 (US$M)
Middle East & Africa 3D Printed Drugs Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
